The Texas Rangers have agreed to terms with right‑handed reliever Alexis Díaz and Tyler Alexander on a one‑year contract, continuing the club’s active offseason pursuit of bullpen acquisitions, according to reports. Díaz and Alexander’s additions come as part of a broader shakeup in Texas’s bullpen, which saw multiple key arms depart via free agency or roster moves this winter, prompting the Rangers to restock with experienced pitchers.
Díaz, 29, enters the 2026 season looking to rebound after a difficult 2025 campaign in which he struggled to find consistency at the major‑league level. Once regarded as one of baseball’s more promising relief pitchers, Díaz burst onto the scene with the Cincinnati Reds after making his MLB debut in 2022. Over his early seasons in the league, he amassed 75 saves and posted solid strikeout totals, establishing himself as a formidable late‑inning arm.
His performance peaked in 2023, when he earned an All‑Star selection, showcasing a fastball/slider combination that generated a high strikeout rate and kept opposing hitters off balance. However, the subsequent seasons saw his effectiveness decline, culminating in a 7.80 ERA pitched in 2025 while splitting time between stints with Cincinnati, the Los Angeles Dodgers, and the Atlanta Braves.
Despite the struggles of the past year, the Rangers are betting on Díaz’s potential to rediscover the form that made him a coveted bullpen asset. Texas has been proactive in shoring up its relief corps after multiple key relievers, including Phil Maton, Chris Martin, Jacob Webb, Hoby Milner, and Danny Coulombe, reached free agency and moved on this winter. The club’s front office moved quickly to add reinforcements, also agreeing to a one‑year deal with lefty Tyler Alexander, giving manager Skip Schumaker additional options out of the bullpen.
For Díaz, the one‑year deal represents an opportunity to reset with a club that expects to compete in the American League West. If he can return to form, Texas could benefit from both depth and late‑inning upside.
The Rangers’ willingness to take on a pitcher with fluctuation in recent results speaks to their broader offseason strategy: adding cost‑controlled arms with upside while preserving flexibility elsewhere on the roster.
